Clik here to view.
#JPM12 takeaway: Big Pharma puts a big hurt on primary care
The JP Morgan Annual Healthcare Conference has become the biggest conference for the industry drawing pharmaceutical and medical device companies, clinical research organizations, and of course, their...
View ArticleClik here to view.
Stryker to acquire MAKO Surgical Corp.
Stryker (SYK) will acquire MAKO Surgical Corp. to the tune of about $1.65 billion. “MAKO has established a compelling technology platform in robotic assisted surgery which we believe has considerable...
View ArticleClik here to view.
Move toward the exits: 8 realistic tips on how to fund your medical device in...
At Advamed 2013, industry leaders met and discussed how startups and innovation can beat the odds without much chance of gaining venture capital at an extremely early stage. Here are realistic options...
View ArticleClik here to view.
Amazon CEO adds second healthcare investment with cancer immunotherapy funding
Amazon founder Jeff Bezos has taken an interest in cancer immunotherapies. The investment in life science innovation marks a shift in his personal investment focus from the technology startups that he...
View ArticleClik here to view.
5 insights from digital health CEOs at JP Morgan Healthcare conference
It’s rare for me to hear a panel discussion on digital health and not hear the same conversation repeated and reiterated over and over again. In a discussion between health IT company CEOs at the JP...
View ArticleClik here to view.
Medtronic-backed Intersect ENT finalizes enrollment for third chronic...
Intersect ENT, a California-based medical devices company with chronic sinusitus drug-delivery solutions, presented a company overview Tuesday at the JP Morgan Healthcare Conference in San Francisco....
View ArticleClik here to view.
xG Health Solutions CEO: We are not looking for every customer
Geisinger Health System’s spinout company, xG Health Solutions, may be looking for provider customers for its healthcare analytics tools and consulting business to help them convert from fee-based to...
View ArticleClik here to view.
Free the data meets quantified self in 23andMe co-founder’s startup, Curious
A new company developed by one of the two co-founders of 23andMe wants to help patients not only analyze their data, but influence how it is used. It reflects the free the data movement to not only...
View Article#JPM14 inspiration: A drinking game for your next life science conference
#suitskate #JPM14 pic.twitter.com/82OVao8Qq7 — Brian Reid (@brianreid) January 14, 2014 The big JPMorgan conference in San Francisco is half over. Two-and-a-half days of entrepreneurs, investors and...
View ArticleClik here to view.
Aetna says private Medicare sign ups better than expected
(Reuters) – Aetna Inc said on Tuesday that based on sign ups for private Medicare, its first-quarter membership for these health plans for seniors would be “meaningfully better” than previously...
View ArticleClik here to view.
Biopharma management team ISO growth-stage companies to advise and direct
The co-founders of 6-month-old consulting company NovoBioPharma want to carve a niche for themselves in the area of helping manage and advise growth-stage life science industry companies — an area they...
View ArticleClik here to view.
9 memorable tweets from JP Morgan Healthcare conference
It’s been a markedly upbeat atmosphere at the JP Morgan Healthcare conference this year. The uncharacteristically sunny, warm weather reflected a shift in outlook from the angst and unease that has...
View ArticleClik here to view.
3 biotech investment trends gleaned from JP Morgan conference
Pharma is warming up to innovation, personal medicine — particularly for oncology — is hot and molecular diagnostics have moved from the bench to the bedside. As bullish as investors seem about biotech...
View ArticleClik here to view.
Is that digital health revenue in your pocket or are you just happy to see me?
The other day I was reading one of MedCity News’ wrap up articles from the JP Morgan Ringling Brothers, Barnum & Bailey Healthcare Circus, which is just folding up tent in San Francisco. Everyone...
View ArticleWhat to expect when you’re expecting… a lot out of the JP Morgan Healthcare...
Four weeks from today, many of us will be dallying at the JP Morgan Healthcare Conference that’s held Jan. 12-15 in San Francisco. Now’s the time to start planning – what to say to that private equity...
View ArticleClik here to view.
Strategy tips for the JP Morgan healthcare conference (and what comes after)
Veterans know the annual JP Morgan Healthcare Conference week in San Francisco isn’t just about the conference. The entire week is an event that includes literally dozens of ancillary gatherings and...
View ArticleClik here to view.
Poltroons and pick-up lines: What’s buzzing at #JPM15
Happy JP MorganWeek! Presenting companies have been bottling up the best news they can muster, to announce with aplomb this week at the premier biotech investing event in the country. It’s already...
View Article#JPM15 Buzz: BIG deals, and a bobblehead
The eve of JP Morgan healthcare investment conference’s launch was marked by binge drinking, a number of big deals – and the bobblehead doppelgänger of TheStreet’s Adam Feuerstein, who shant be at this...
View ArticleClik here to view.
Qualcomm and Novartis Part 2: Let’s start an investment company
The Beyond the Pill movement took an interesting turn this week when Qualcomm announced plans to open an investment business with Novartis, according to a company statement. Qualcomm will launch the...
View ArticleClik here to view.
Ginger.io raises $20M partly to support R&D expansion to monitor chronic...
Following on the heels of some high-profile partnerships with medical and research centers last year, Ginger.io has raised $20 million from new investor Kaiser Permanente Ventures, along with returning...
View Article
